Our Services
Medical Information
Helpful Resources
Published on: 10/1/2026
A measles immunity test is usually a blood draw called a measles IgG antibody titer, which looks for protective antibodies your body made after vaccination or a past infection, rather than detecting an active illness. Results come back as immune (positive), not immune (negative), or equivocal, and a negative or borderline result most often means an additional MMR dose is advised, not that something went wrong with your earlier shots. To request one, ask your primary care clinician, an urgent care, or your workplace, campus, or travel health office for a "measles IgG titer," explain your reason (recent exposure, international travel, healthcare or school requirements, pregnancy planning, or lost vaccine records), and ask whether mumps, rubella, and varicella titers should be drawn at the same time. Timing after exposure, insurance coverage, and how to interpret equivocal results all change what you should do next, so see below for the complete answer before you call.
If you are asking about immunity because you already feel unwell, have a fever and rash, or know you were around someone with measles, waiting on a titer may not be the fastest way to protect yourself and the people near you, since measles spreads before the rash appears and some symptoms point to very different causes; a free, instant, online symptom check can help you organize what you are experiencing, see which conditions fit the pattern, and walk into your appointment knowing which test and level of care to ask for.
Last reviewed for medical accuracy: 10/01/2025
A measles immunity test is a simple blood test that measures whether you have protective antibodies against measles. It’s often called a “measles IgG antibody titer” or “MMR titer” when combined with mumps and rubella. Knowing your immunity status helps you and your doctor decide if you need a vaccine booster or other precautions.
Measles-specific IgG antibodies
The test detects immunoglobulin G (IgG) antibodies in your blood that target the measles virus. IgG is the type of antibody responsible for long-term protection.
Antibody level (titer)
Your lab report will show a numerical “titer” or concentration of measles IgG. Results above a certain threshold indicate immunity; below that threshold suggests you may be susceptible.
Protective threshold
While cutoffs vary by lab, a titer of about 120 mIU/mL (milli-International Units per milliliter) or higher usually means you’re protected. Always review your specific lab’s reference range.
Travel requirements
If you plan to visit areas with measles outbreaks, proof of immunity may be required for entry or recommended by travel clinics.
Occupational guidelines
Healthcare workers, school employees, or anyone working with vulnerable populations (infants, pregnant women, immunocompromised people) often need documented immunity.
Uncertain vaccine history
Many adults can’t recall whether they completed their two-dose MMR vaccine series. A titer test provides clarity.
Pregnancy planning
Pregnant women or those planning pregnancy benefit from confirmed immunity, since measles infection during pregnancy can be serious.
You might ask for a measles immunity test if you:
Blood draw
A small sample of blood is taken from a vein, usually in your arm.
Laboratory analysis
The lab runs an enzyme-linked immunosorbent assay (ELISA) or similar method to measure measles IgG levels.
Result turnaround
Most labs deliver results in 1–5 business days. Your provider will notify you or upload results to your patient portal.
Clear communication helps ensure you get exactly the test you need. Here’s how to approach your doctor or nurse:
Be specific
“I’d like a measles IgG antibody titer to check my immunity.”
Mention reasons
“I’m planning to travel internationally and want to confirm my measles immunity,” or “I work in healthcare and need documented protection.”
Reference guidelines
“The CDC and WHO recommend a measles immunity check if vaccine history is unclear.”
Verify insurance coverage
Ask if your insurance covers an “MMR titer” or “measles IgG test.” Some plans label it under “rubella, mumps, measles antibody screen.”
Lab orders
If you have direct-access testing in your state, you might order a “measles IgG antibody titer” online and visit a lab without a doctor’s order.
Once you receive your lab report:
Positive/immune
Your antibody level meets or exceeds the lab’s protective cutoff. No additional vaccine dose is usually needed.
Negative/non-immune
Your antibody level is below the cutoff. Discuss vaccination with your doctor—usually one MMR dose is recommended.
Equivocal/indeterminate
Your antibody level falls into a gray zone. A repeat test or a vaccine dose may be advised.
Always review results with your healthcare provider to understand what they mean for your health.
To stay informed about measles immunity testing, rely on these expert organizations:
Centers for Disease Control and Prevention (CDC)
Recommendations on measles testing and vaccination.
World Health Organization (WHO)
Global guidelines for measles surveillance and immunity.
Lab corporations (Quest, LabCorp)
Detailed test descriptions and reference ranges.
Academic medical centers (Mayo Clinic, Johns Hopkins)
Patient-friendly overviews and Q&A sections.
Measles is highly contagious but largely preventable with immunity. A measles immunity test is a straightforward way to confirm you’re protected. If you learn you’re not immune, a single MMR vaccine dose is safe and effective for most adults.
Should you experience any symptoms that concern you—fever, rash, cough, red eyes—consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
If you encounter any of the following, seek medical attention promptly:
Always discuss any health concerns or test interpretations with a qualified healthcare professional.
(References)
* Schluederberg A, Lamm SH, Landrigan PJ, Black FL. Measles immunity in children vaccinated before one year of age. Am J Epidemiol. 1973 Jun;97(6):402-9. doi: 10.1093/oxfordjournals.aje.a121521. PMID: 4713935.
* Bolomovskiĭ VM, Gelikman BG, Titova NS, Slavnitskaia IV, Auzinia AV. [Immunological effectiveness of a booster inoculation against measles in children remaining seronegative after vaccination]. Zh Mikrobiol Epidemiol Immunobiol. 1984 Jul;(7):100-6. PMID: 6333122.
* Gonçalves G, Cutts F, Forsey T, Andrade HR. Comparison of a commercial enzyme immunoassay with plaque reduction neutralization for maternal and infant measles antibody measurement. Rev Inst Med Trop Sao Paulo. 1999 Jan-Feb;41(1):21-6. doi: 10.1590/s0036-46651999000100005. PMID: 10436666.
* Stittelaar KJ, de Swart RL, Vos HW, van Amerongen G, Agafonov AP, Nechaeva EA, Osterhaus AD. Enteric administration of a live attenuated measles vaccine does not induce protective immunity in a macaque model. Vaccine. 2002 Jul 26;20(23-24):2906-12. doi: 10.1016/s0264-410x(02)00231-1. PMID: 12126901.
* Bouche FB, Marquet-Blouin E, Yanagi Y, Steinmetz A, Muller CP. Neutralising immunogenicity of a polyepitope antigen expressed in a transgenic food plant: a novel antigen to protect against measles. Vaccine. 2003 May 16;21(17-18):2065-72. doi: 10.1016/s0264-410x(02)00747-8. PMID: 12706696.
* CHU CM, KU YF, CHANG YH. OBSERVATIONS ON THE FURTHER ATTENUATION OF MEASLES VIRUS AND ON LIVE VACCINES PREPARED FROM HIGHLY ATTENUATED LINES OF VIRUS. Chin Med J. 1964 Aug;83:483-96. PMID: 14174535.
* DREVO M, ZAVADOVA H, MARES I, ADAM E. [USE OF THE NEUTRALIZATION TEST AND THE COMPLEMENT FIXATION REACTION FOR DEMONSTRATION OF ANTI BODIES AGAINST MEASLES]. Cas Lek Cesk. 1965 Jan 15;104:47-9. PMID: 14282948.
* KRUGMAN S. MEASLES IMMUNIZATION: COMBINED VACCINATIONS. Arch Gesamte Virusforsch. 1965;16:339-42. doi: 10.1007/BF01253834. PMID: 14322890.
* Farcet MR, Karbiener M, Rabel PO, Schirmer A, Ilk R, Kreil TR. Measles virus neutralizing antibodies in immunoglobulin lots produced from plasma collected in Europe or the United States. Vaccine. 2019 May 27;37(24):3151-3153. doi: 10.1016/j.vaccine.2019.04.022. Epub 2019 May 3. PMID: 31060953.
* Metcalf CJE, Wesolowski A, Winter AK, Lessler J, Cauchemez S, Moss WJ, McLean AR, Grenfell BT. Using Serology to Anticipate Measles Post-honeymoon Period Outbreaks. Trends Microbiol. 2020 Aug;28(8):597-600. doi: 10.1016/j.tim.2020.04.009. Epub 2020 Apr 20. PMID: 32359782; PMCID: PMC7167541.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.